The medical education landscape has changed dramatically for the pharmaceutical sector. As regulatory and market pressures have reshaped approaches to Continuing Medical Education programs, pharmaceutical organizations are struggling to have the right staffing, investment, and delivery platforms to provide valuable education opportunities for healthcare practitioners.
A new study was conducted by medical education leaders on current approaches to medical education group size, service-levels, resources, and program deployment,
The study, “Professional Medical Education Excellence: Structures, Resources, Services & Performance Levels to Optimize Pharmaceutical Education Groups provides segments for both pharmaceutical and medical device leaders.
It also presents medical education leaders’ perspective on current and future trends for staffing and investment.
Education leaders will also be taught about trends in the use of technology for education, the presence of education in emerging markets and how education groups are allocating their budget.
The research project found that on-demand Medical Education programs have proven popular in both pharmaceutical and device sectors as it offers busy physicians the flexibility to choose their timing for education. Almost 60 percent of the pharmaceutical segments’ education programs in the past year were either on-demand or online Webcasts, according to the study.
This 85-page study covers the following topics:
-- Organizational Fit & Geographic Focus
-- Staffing Benchmarks & Program Trends
-- Roles for Key Activities & Program Deployment
-- Budget Benchmarks & Allocation Trends
-- Trends & Directions
The research project included observations and insights from 40 leaders with 35 medical device and pharmaceutical companies. Participants included 14 medical education leaders from 10 medical device firms and 26 leaders from 25 bio-pharmaceutical companies.
